inotuzumab,blinatumomab
amgen,ucb pharmaceuticals,pfizer
['blinatumomab', 'inotuzumab', 'leusm', 'leukemia']
coming up shortly: chemotherapy-free treatment of newly-diagnosed ph-negative cd22+ b-cell all with blinatumomab and inotuzumab. would love to kick chemo to the curb in leukemia care! important study #asco23 #leusm
Patient experience & cancer outcomes researcher | Leukemia & palliative care doc | Chief PX and Safety Officer @DukeCancer | HeForShe. Tweets mine.